Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 06, 2026 BOSTON, Jan. 06, 2026 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will be presenting and hosting 1×1 investor meetings at the 44th Annual J.P. Morgan […]

Apollo to Announce Fourth Quarter and Full Year 2025 Financial Results on February 9, 2026

Apollo to Announce Fourth Quarter and Full Year 2025 Financial Results on February 9, 2026 GlobeNewswire January 06, 2026 NEW YORK, Jan. 06, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) plans to release financial results for the fourth quarter and full year 2025 on Monday, February 9, 2026, before the opening of trading on the

Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference

(NASDAQ:RXRX), Salt Lake City, Jan. 06, 2026 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13, 10:30am PT at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco. Management will

Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference

Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 06, 2026 Salt Lake City, Jan. 06, 2026 (GLOBE NEWSWIRE) — Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13, 10:30am PT at

Calvetti Ferguson Promotes Renato Antun to Tax Partner, Strengthening Nashville Market

NASHVILLE, Tenn., Jan. 06, 2026 (GLOBE NEWSWIRE) — Calvetti Ferguson has promoted Renato Antun to tax partner. Based in the Nashville office, Renato has played a crucial role in reinforcing Calvetti Ferguson's commitment to delivering specialized, high-value tax solutions for a variety of industries across the Tennessee market. Since joining Calvetti Ferguson in 2024, Renato

Levi & Korsinsky Releases SueWallSt Podcast on Stride, Inc. (LRN) Lawsuit

NEW YORK, NY / ACCESS Newswire / January 6, 2026 / Levi & Korsinsky, LLP releases a Podcast regarding Stride, Inc. (NYSE:LRN) class action securities lawsuit A Class Action lawsuit was filed on behalf of Stride, Inc. investors who lost money as a result of alleged securities fraud between October 22, 2024 and October 28,

Calvetti Ferguson Promotes Renato Antun to Tax Partner, Strengthening Nashville Market

Calvetti Ferguson Promotes Renato Antun to Tax Partner, Strengthening Nashville Market GlobeNewswire January 06, 2026 NASHVILLE, Tenn., Jan. 06, 2026 (GLOBE NEWSWIRE) — Calvetti Ferguson has promoted Renato Antun to tax partner. Based in the Nashville office, Renato has played a crucial role in reinforcing Calvetti Ferguson's commitment to delivering specialized, high-value tax solutions for

SueWallSt Podcast Update: Levi & Korsinsky Details FLY Class Action Claims

NEW YORK, NY / ACCESS Newswire / January 6, 2026 / Levi & Korsinsky, LLP releases a Podcast regarding Firefly Aerospace Inc. (NASDAQ:FLY) class action securities lawsuit This lawsuit is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired: (a) Firefly common stock pursuant and/or

Johns Hopkins Medicine Treats First Commercial TULSA-PRO(R) Case

(TSX:PRN),(NASDAQ:PROF), TORONTO, Jan. 06, 2026 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue, today announced that The Johns Hopkins Hospital has treated its first non-clinical-trial prostate cancer patient using the Company's TULSA-PRO(R)

Scroll to Top